APO Research
Talk to an analyst

APO RESEARCH · REPORT

Bromhidrosis Disease Treatment

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Bromhidrosis Disease Treatment Market Analysis and Forecast 2026-2032

22 December 2025196 pages

Choose your research edition.

Industry ResearchBromhidrosis Disease Treatment Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Bromhidrosis Disease Treatment Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Bromhidrosis Disease Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Bromhidrosis Disease Treatment Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Bromhidrosis Disease Treatment Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Bromhidrosis Disease Treatment market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Bromhidrosis Disease Treatment is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Bromhidrosis Disease Treatment is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Bromhidrosis Disease Treatment is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Bromhidrosis Disease Treatment is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Bromhidrosis Disease Treatment include Johnson and Johnson, Novartis AG, Pfizer, AbbVie, Merz Pharma GmbH and Co. KGaA, Medytox, Journey Medical Corp, Ipsen Pharma and Hikma Pharmaceuticals, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Bromhidrosis Disease Treatment, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Bromhidrosis Disease Treatment, also provides the sales of main regions and countries. Of the upcoming market potential for Bromhidrosis Disease Treatment, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Bromhidrosis Disease Treatment sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Bromhidrosis Disease Treatment market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Bromhidrosis Disease Treatment sales, projected growth trends, production technology, application and end-user industry.

Bromhidrosis Disease Treatment Segment by Company

Johnson and Johnson

Novartis AG

Pfizer

AbbVie

Merz Pharma GmbH and Co. KGaA

Medytox

Journey Medical Corp

Ipsen Pharma

Hikma Pharmaceuticals

Galderma SA

Boehringer Ingelheim International GmbH

Biovencer Healthcare

Bromhidrosis Disease Treatment Segment by Type

Antiperspirants

Botulinum Toxin

Topical Antiseptic

Bromhidrosis Disease Treatment Segment by Application

Hospital

Drugs Store

Other

Bromhidrosis Disease Treatment Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bromhidrosis Disease Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Bromhidrosis Disease Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bromhidrosis Disease Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Bromhidrosis Disease Treatment in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Bromhidrosis Disease Treatment manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Bromhidrosis Disease Treatment sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Bromhidrosis Disease Treatment Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Antiperspirants Major Manufacturers Table 3. Botulinum Toxin Major Manufacturers Table 4. Topical Antiseptic Major Manufacturers Table 5. Global Bromhidrosis Disease Treatment Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Hospital Major Manufacturers Table 7. Drugs Store Major Manufacturers Table 8. Other Major Manufacturers Table 9. Bromhidrosis Disease Treatment Industry Trends Table 10. Bromhidrosis Disease Treatment Industry Drivers Table 11. Bromhidrosis Disease Treatment Industry Opportunities and Challenges Table 12. Bromhidrosis Disease Treatment Industry Restraints Table 13. Global Bromhidrosis Disease Treatment Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Bromhidrosis Disease Treatment Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Bromhidrosis Disease Treatment Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Bromhidrosis Disease Treatment Revenue Market Share by Region (2021-2026) Table 17. Global Bromhidrosis Disease Treatment Revenue Market Share by Region (2027-2032) Table 18. Global Bromhidrosis Disease Treatment Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 19. Global Bromhidrosis Disease Treatment Sales by Region (2021-2026) & (k units) Table 20. Global Bromhidrosis Disease Treatment Sales by Region (2027-2032) & (k units) Table 21. Global Bromhidrosis Disease Treatment Sales Market Share by Region (2021-2026) Table 22. Global Bromhidrosis Disease Treatment Sales Market Share by Region (2027-2032) Table 23. Global Bromhidrosis Disease Treatment Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Bromhidrosis Disease Treatment Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Bromhidrosis Disease Treatment Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Bromhidrosis Disease Treatment Sales Market Share by Manufacturers (2021-2026) Table 27. Global Bromhidrosis Disease Treatment Sales Price (US$/unit) of Manufacturers (2021-2026) Table 28. Global Bromhidrosis Disease Treatment Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Bromhidrosis Disease Treatment Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Bromhidrosis Disease Treatment Manufacturers, Product Type & Application Table 31. Global Bromhidrosis Disease Treatment Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Bromhidrosis Disease Treatment by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Bromhidrosis Disease Treatment Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Bromhidrosis Disease Treatment Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Bromhidrosis Disease Treatment Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Bromhidrosis Disease Treatment Revenue Market Share by Type (2021-2026) Table 38. Global Bromhidrosis Disease Treatment Revenue Market Share by Type (2027-2032) Table 39. Global Bromhidrosis Disease Treatment Sales by Type 2021 VS 2025 VS 2032 (k units) Table 40. Global Bromhidrosis Disease Treatment Sales by Type (2021-2026) & (k units) Table 41. Global Bromhidrosis Disease Treatment Sales by Type (2027-2032) & (k units) Table 42. Global Bromhidrosis Disease Treatment Sales Market Share by Type (2021-2026) Table 43. Global Bromhidrosis Disease Treatment Sales Market Share by Type (2027-2032) Table 44. Global Bromhidrosis Disease Treatment Price by Type (2021-2026) & (US$/unit) Table 45. Global Bromhidrosis Disease Treatment Price by Type (2027-2032) & (US$/unit) Table 46. Global Bromhidrosis Disease Treatment Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Bromhidrosis Disease Treatment Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Bromhidrosis Disease Treatment Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Bromhidrosis Disease Treatment Revenue Market Share by Application (2021-2026) Table 50. Global Bromhidrosis Disease Treatment Revenue Market Share by Application (2027-2032) Table 51. Global Bromhidrosis Disease Treatment Sales by Application 2021 VS 2025 VS 2032 (k units) Table 52. Global Bromhidrosis Disease Treatment Sales by Application (2021-2026) & (k units) Table 53. Global Bromhidrosis Disease Treatment Sales by Application (2027-2032) & (k units) Table 54. Global Bromhidrosis Disease Treatment Sales Market Share by Application (2021-2026) Table 55. Global Bromhidrosis Disease Treatment Sales Market Share by Application (2027-2032) Table 56. Global Bromhidrosis Disease Treatment Price by Application (2021-2026) & (US$/unit) Table 57. Global Bromhidrosis Disease Treatment Price by Application (2027-2032) & (US$/unit) Table 58. Johnson and Johnson Company Information Table 59. Johnson and Johnson Business Overview Table 60. Johnson and Johnson Bromhidrosis Disease Treatment Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 61. Johnson and Johnson Bromhidrosis Disease Treatment Product Portfolio Table 62. Johnson and Johnson Recent Development Table 63. Novartis AG Company Information Table 64. Novartis AG Business Overview Table 65. Novartis AG Bromhidrosis Disease Treatment Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 66. Novartis AG Bromhidrosis Disease Treatment Product Portfolio Table 67. Novartis AG Recent Development Table 68. Pfizer Company Information Table 69. Pfizer Business Overview Table 70. Pfizer Bromhidrosis Disease Treatment Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 71. Pfizer Bromhidrosis Disease Treatment Product Portfolio Table 72. Pfizer Recent Development Table 73. AbbVie Company Information Table 74. AbbVie Business Overview Table 75. AbbVie Bromhidrosis Disease Treatment Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 76. AbbVie Bromhidrosis Disease Treatment Product Portfolio Table 77. AbbVie Recent Development Table 78. Merz Pharma GmbH and Co. KGaA Company Information Table 79. Merz Pharma GmbH and Co. KGaA Business Overview Table 80. Merz Pharma GmbH and Co. KGaA Bromhidrosis Disease Treatment Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 81. Merz Pharma GmbH and Co. KGaA Bromhidrosis Disease Treatment Product Portfolio Table 82. Merz Pharma GmbH and Co. KGaA Recent Development Table 83. Medytox Company Information Table 84. Medytox Business Overview Table 85. Medytox Bromhidrosis Disease Treatment Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 86. Medytox Bromhidrosis Disease Treatment Product Portfolio Table 87. Medytox Recent Development Table 88. Journey Medical Corp Company Information Table 89. Journey Medical Corp Business Overview Table 90. Journey Medical Corp Bromhidrosis Disease Treatment Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 91. Journey Medical Corp Bromhidrosis Disease Treatment Product Portfolio Table 92. Journey Medical Corp Recent Development Table 93. Ipsen Pharma Company Information Table 94. Ipsen Pharma Business Overview Table 95. Ipsen Pharma Bromhidrosis Disease Treatment Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 96. Ipsen Pharma Bromhidrosis Disease Treatment Product Portfolio Table 97. Ipsen Pharma Recent Development Table 98. Hikma Pharmaceuticals Company Information Table 99. Hikma Pharmaceuticals Business Overview Table 100. Hikma Pharmaceuticals Bromhidrosis Disease Treatment Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 101. Hikma Pharmaceuticals Bromhidrosis Disease Treatment Product Portfolio Table 102. Hikma Pharmaceuticals Recent Development Table 103. Galderma SA Company Information Table 104. Galderma SA Business Overview Table 105. Galderma SA Bromhidrosis Disease Treatment Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 106. Galderma SA Bromhidrosis Disease Treatment Product Portfolio Table 107. Galderma SA Recent Development Table 108. Boehringer Ingelheim International GmbH Company Information Table 109. Boehringer Ingelheim International GmbH Business Overview Table 110. Boehringer Ingelheim International GmbH Bromhidrosis Disease Treatment Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 111. Boehringer Ingelheim International GmbH Bromhidrosis Disease Treatment Product Portfolio Table 112. Boehringer Ingelheim International GmbH Recent Development Table 113. Biovencer Healthcare Company Information Table 114. Biovencer Healthcare Business Overview Table 115. Biovencer Healthcare Bromhidrosis Disease Treatment Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 116. Biovencer Healthcare Bromhidrosis Disease Treatment Product Portfolio Table 117. Biovencer Healthcare Recent Development Table 118. North America Bromhidrosis Disease Treatment Revenue by Type (2021-2026) & (US$ Million) Table 119. North America Bromhidrosis Disease Treatment Revenue by Type (2027-2032) & (US$ Million) Table 120. North America Bromhidrosis Disease Treatment Sales by Type (2021-2026) & (k units) Table 121. North America Bromhidrosis Disease Treatment Sales by Type (2027-2032) & (k units) Table 122. North America Bromhidrosis Disease Treatment Sales Price by Type (2021-2026) & (US$/unit) Table 123. North America Bromhidrosis Disease Treatment Sales Price by Type (2027-2032) & (US$/unit) Table 124. North America Bromhidrosis Disease Treatment Revenue by Application (2021-2026) & (US$ Million) Table 125. North America Bromhidrosis Disease Treatment Revenue by Application (2027-2032) & (US$ Million) Table 126. North America Bromhidrosis Disease Treatment Sales by Application (2021-2026) & (k units) Table 127. North America Bromhidrosis Disease Treatment Sales by Application (2027-2032) & (k units) Table 128. North America Bromhidrosis Disease Treatment Sales Price by Application (2021-2026) & (US$/unit) Table 129. North America Bromhidrosis Disease Treatment Sales Price by Application (2027-2032) & (US$/unit) Table 130. North America Bromhidrosis Disease Treatment Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 131. North America Bromhidrosis Disease Treatment Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 132. North America Bromhidrosis Disease Treatment Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 133. North America Bromhidrosis Disease Treatment Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 134. North America Bromhidrosis Disease Treatment Sales by Country (2021-2026) & (k units) Table 135. North America Bromhidrosis Disease Treatment Sales by Country (2027-2032) & (k units) Table 136. North America Bromhidrosis Disease Treatment Sales Price by Country (2021-2026) & (US$/unit) Table 137. North America Bromhidrosis Disease Treatment Sales Price by Country (2027-2032) & (US$/unit) Table 138. United States Bromhidrosis Disease Treatment Revenue (2021-2032) & (US$ Million) Table 139. Canada Bromhidrosis Disease Treatment Revenue (2021-2032) & (US$ Million) Table 140. Mexico Bromhidrosis Disease Treatment Revenue (2021-2032) & (US$ Million) Table 141. Europe Bromhidrosis Disease Treatment Revenue by Type (2021-2026) & (US$ Million) Table 142. Europe Bromhidrosis Disease Treatment Revenue by Type (2027-2032) & (US$ Million) Table 143. Europe Bromhidrosis Disease Treatment Sales by Type (2021-2026) & (k units) Table 144. Europe Bromhidrosis Disease Treatment Sales by Type (2027-2032) & (k units) Table 145. Europe Bromhidrosis Disease Treatment Sales Price by Type (2021-2026) & (US$/unit) Table 146. Europe Bromhidrosis Disease Treatment Sales Price by Type (2027-2032) & (US$/unit) Table 147. Europe Bromhidrosis Disease Treatment Revenue by Application (2021-2026) & (US$ Million) Table 148. Europe Bromhidrosis Disease Treatment Revenue by Application (2027-2032) & (US$ Million) Table 149. Europe Bromhidrosis Disease Treatment Sales by Application (2021-2026) & (k units) Table 150. Europe Bromhidrosis Disease Treatment Sales by Application (2027-2032) & (k units) Table 151. Europe Bromhidrosis Disease Treatment Sales Price by Application (2021-2026) & (US$/unit) Table 152. Europe Bromhidrosis Disease Treatment Sales Price by Application (2027-2032) & (US$/unit) Table 153. Europe Bromhidrosis Disease Treatment Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 154. Europe Bromhidrosis Disease Treatment Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 155. Europe Bromhidrosis Disease Treatment Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 156. Europe Bromhidrosis Disease Treatment Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 157. Europe Bromhidrosis Disease Treatment Sales by Country (2021-2026) & (k units) Table 158. Europe Bromhidrosis Disease Treatment Sales by Country (2027-2032) & (k units) Table 159. Europe Bromhidrosis Disease Treatment Sales Price by Country (2021-2026) & (US$/unit) Table 160. Europe Bromhidrosis Disease Treatment Sales Price by Country (2027-2032) & (US$/unit) Table 161. Germany Bromhidrosis Disease Treatment Revenue (2021-2032) & (US$ Million) Table 162. France Bromhidrosis Disease Treatment Revenue (2021-2032) & (US$ Million) Table 163. U.K. Bromhidrosis Disease Treatment Revenue (2021-2032) & (US$ Million) Table 164. Italy Bromhidrosis Disease Treatment Revenue (2021-2032) & (US$ Million) Table 165. Russia Bromhidrosis Disease Treatment Revenue (2021-2032) & (US$ Million) Table 166. Spain Bromhidrosis Disease Treatment Revenue (2021-2032) & (US$ Million) Table 167. Netherlands Bromhidrosis Disease Treatment Revenue (2021-2032) & (US$ Million) Table 168. Switzerland Bromhidrosis Disease Treatment Revenue (2021-2032) & (US$ Million) Table 169. Sweden Bromhidrosis Disease Treatment Revenue (2021-2032) & (US$ Million) Table 170. Poland Bromhidrosis Disease Treatment Revenue (2021-2032) & (US$ Million) Table 171. China Bromhidrosis Disease Treatment Revenue by Type (2021-2026) & (US$ Million) Table 172. China Bromhidrosis Disease Treatment Revenue by Type (2027-2032) & (US$ Million) Table 173. China Bromhidrosis Disease Treatment Sales by Type (2021-2026) & (k units) Table 174. China Bromhidrosis Disease Treatment Sales by Type (2027-2032) & (k units) Table 175. China Bromhidrosis Disease Treatment Sales Price by Type (2021-2026) & (US$/unit) Table 176. China Bromhidrosis Disease Treatment Sales Price by Type (2027-2032) & (US$/unit) Table 177. China Bromhidrosis Disease Treatment Revenue by Application (2021-2026) & (US$ Million) Table 178. China Bromhidrosis Disease Treatment Revenue by Application (2027-2032) & (US$ Million) Table 179. China Bromhidrosis Disease Treatment Sales by Application (2021-2026) & (k units) Table 180. China Bromhidrosis Disease Treatment Sales by Application (2027-2032) & (k units) Table 181. China Bromhidrosis Disease Treatment Sales Price by Application (2021-2026) & (US$/unit) Table 182. China Bromhidrosis Disease Treatment Sales Price by Application (2027-2032) & (US$/unit) Table 183. Asia Bromhidrosis Disease Treatment Revenue by Type (2021-2026) & (US$ Million) Table 184. Asia Bromhidrosis Disease Treatment Revenue by Type (2027-2032) & (US$ Million) Table 185. Asia Bromhidrosis Disease Treatment Sales by Type (2021-2026) & (k units) Table 186. Asia Bromhidrosis Disease Treatment Sales by Type (2027-2032) & (k units) Table 187. Asia Bromhidrosis Disease Treatment Sales Price by Type (2021-2026) & (US$/unit) Table 188. Asia Bromhidrosis Disease Treatment Sales Price by Type (2027-2032) & (US$/unit) Table 189. Asia Bromhidrosis Disease Treatment Revenue by Application (2021-2026) & (US$ Million) Table 190. Asia Bromhidrosis Disease Treatment Revenue by Application (2027-2032) & (US$ Million) Table 191. Asia Bromhidrosis Disease Treatment Sales by Application (2021-2026) & (k units) Table 192. Asia Bromhidrosis Disease Treatment Sales by Application (2027-2032) & (k units) Table 193. Asia Bromhidrosis Disease Treatment Sales Price by Application (2021-2026) & (US$/unit) Table 194. Asia Bromhidrosis Disease Treatment Sales Price by Application (2027-2032) & (US$/unit) Table 195. Asia Bromhidrosis Disease Treatment Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 196. Asia Bromhidrosis Disease Treatment Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 197. Asia Bromhidrosis Disease Treatment Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 198. Asia Bromhidrosis Disease Treatment Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 199. Asia Bromhidrosis Disease Treatment Sales by Country (2021-2026) & (k units) Table 200. Asia Bromhidrosis Disease Treatment Sales by Country (2027-2032) & (k units) Table 201. Asia Bromhidrosis Disease Treatment Sales Price by Country (2021-2026) & (US$/unit) Table 202. Asia Bromhidrosis Disease Treatment Sales Price by Country (2027-2032) & (US$/unit) Table 203. Japan Bromhidrosis Disease Treatment Revenue (2021-2032) & (US$ Million) Table 204. South Korea Bromhidrosis Disease Treatment Revenue (2021-2032) & (US$ Million) Table 205. India Bromhidrosis Disease Treatment Revenue (2021-2032) & (US$ Million) Table 206. Australia Bromhidrosis Disease Treatment Revenue (2021-2032) & (US$ Million) Table 207. Taiwan Bromhidrosis Disease Treatment Revenue (2021-2032) & (US$ Million) Table 208. Southeast Asia Bromhidrosis Disease Treatment Revenue (2021-2032) & (US$ Million) Table 209. SAMEA Bromhidrosis Disease Treatment Revenue by Type (2021-2026) & (US$ Million) Table 210. SAMEA Bromhidrosis Disease Treatment Revenue by Type (2027-2032) & (US$ Million) Table 211. SAMEA Bromhidrosis Disease Treatment Sales by Type (2021-2026) & (k units) Table 212. SAMEA Bromhidrosis Disease Treatment Sales by Type (2027-2032) & (k units) Table 213. SAMEA Bromhidrosis Disease Treatment Sales Price by Type (2021-2026) & (US$/unit) Table 214. SAMEA Bromhidrosis Disease Treatment Sales Price by Type (2027-2032) & (US$/unit) Table 215. SAMEA Bromhidrosis Disease Treatment Revenue by Application (2021-2026) & (US$ Million) Table 216. SAMEA Bromhidrosis Disease Treatment Revenue by Application (2027-2032) & (US$ Million) Table 217. SAMEA Bromhidrosis Disease Treatment Sales by Application (2021-2026) & (k units) Table 218. SAMEA Bromhidrosis Disease Treatment Sales by Application (2027-2032) & (k units) Table 219. SAMEA Bromhidrosis Disease Treatment Sales Price by Application (2021-2026) & (US$/unit) Table 220. SAMEA Bromhidrosis Disease Treatment Sales Price by Application (2027-2032) & (US$/unit) Table 221. SAMEA Bromhidrosis Disease Treatment Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 222. SAMEA Bromhidrosis Disease Treatment Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 223. SAMEA Bromhidrosis Disease Treatment Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 224. SAMEA Bromhidrosis Disease Treatment Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 225. SAMEA Bromhidrosis Disease Treatment Sales by Country (2021-2026) & (k units) Table 226. SAMEA Bromhidrosis Disease Treatment Sales by Country (2027-2032) & (k units) Table 227. SAMEA Bromhidrosis Disease Treatment Sales Price by Country (2021-2026) & (US$/unit) Table 228. SAMEA Bromhidrosis Disease Treatment Sales Price by Country (2027-2032) & (US$/unit) Table 229. Brazil Bromhidrosis Disease Treatment Revenue (2021-2032) & (US$ Million) Table 230. Argentina Bromhidrosis Disease Treatment Revenue (2021-2032) & (US$ Million) Table 231. Chile Bromhidrosis Disease Treatment Revenue (2021-2032) & (US$ Million) Table 232. Colombia Bromhidrosis Disease Treatment Revenue (2021-2032) & (US$ Million) Table 233. Peru Bromhidrosis Disease Treatment Revenue (2021-2032) & (US$ Million) Table 234. Saudi Arabia Bromhidrosis Disease Treatment Revenue (2021-2032) & (US$ Million) Table 235. Israel Bromhidrosis Disease Treatment Revenue (2021-2032) & (US$ Million) Table 236. UAE Bromhidrosis Disease Treatment Revenue (2021-2032) & (US$ Million) Table 237. Turkey Bromhidrosis Disease Treatment Revenue (2021-2032) & (US$ Million) Table 238. Iran Bromhidrosis Disease Treatment Revenue (2021-2032) & (US$ Million) Table 239. Egypt Bromhidrosis Disease Treatment Revenue (2021-2032) & (US$ Million) Table 240. Key Raw Materials Table 241. Raw Materials Key Suppliers Table 242. Bromhidrosis Disease Treatment Distributors List Table 243. Bromhidrosis Disease Treatment Customers List Table 244. Research Programs/Design for This Report Table 245. Authors List of This Report Table 246. Secondary Sources Table 247. Primary Sources List of Figures Figure 1. Bromhidrosis Disease Treatment Image Figure 2. Global Bromhidrosis Disease Treatment Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Bromhidrosis Disease Treatment Market Size Share 2021 VS 2025 VS 2032 Figure 4. Antiperspirants Image Figure 5. Botulinum Toxin Image Figure 6. Topical Antiseptic Image Figure 7. Global Bromhidrosis Disease Treatment Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Bromhidrosis Disease Treatment Market Size Share 2021 VS 2025 VS 2032 Figure 9. Hospital Image Figure 10. Drugs Store Image Figure 11. Other Image Figure 12. Global Bromhidrosis Disease Treatment Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Bromhidrosis Disease Treatment Revenue (2021-2032) & (US$ Million) Figure 14. Global Bromhidrosis Disease Treatment Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Bromhidrosis Disease Treatment Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Bromhidrosis Disease Treatment Revenue Market Share by Region (2021-2032) Figure 17. Global Bromhidrosis Disease Treatment Sales (2021-2032) & (k units) Figure 18. Global Bromhidrosis Disease Treatment Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 19. Global Bromhidrosis Disease Treatment Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Bromhidrosis Disease Treatment Sales YoY (2021-2032) & (k units) Figure 21. Europe Bromhidrosis Disease Treatment Sales YoY (2021-2032) & (k units) Figure 22. China Bromhidrosis Disease Treatment Sales YoY (2021-2032) & (k units) Figure 23. Asia (Excluding China) Bromhidrosis Disease Treatment Sales YoY (2021-2032) & (k units) Figure 24. South America, Middle East and Africa Bromhidrosis Disease Treatment Sales YoY (2021-2032) & (k units) Figure 25. Global Bromhidrosis Disease Treatment Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Bromhidrosis Disease Treatment Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Bromhidrosis Disease Treatment Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Bromhidrosis Disease Treatment Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Bromhidrosis Disease Treatment Revenue Market Share by Type (2021-2032) Figure 31. Global Bromhidrosis Disease Treatment Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 32. Global Bromhidrosis Disease Treatment Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Bromhidrosis Disease Treatment Sales Market Share by Type (2021-2032) Figure 34. Global Bromhidrosis Disease Treatment Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Bromhidrosis Disease Treatment Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Bromhidrosis Disease Treatment Revenue Market Share by Application (2021-2032) Figure 37. Global Bromhidrosis Disease Treatment Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 38. Global Bromhidrosis Disease Treatment Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Bromhidrosis Disease Treatment Sales Market Share by Application (2021-2032) Figure 40. North America Bromhidrosis Disease Treatment Revenue Share by Type (2021-2032) Figure 41. North America Bromhidrosis Disease Treatment Sales Share by Type (2021-2032) Figure 42. North America Bromhidrosis Disease Treatment Revenue Share by Application (2021-2032) Figure 43. North America Bromhidrosis Disease Treatment Sales Share by Application (2021-2032) Figure 44. North America Bromhidrosis Disease Treatment Revenue Share by Country (2021-2032) Figure 45. North America Bromhidrosis Disease Treatment Sales Share by Country (2021-2032) Figure 46. Europe Bromhidrosis Disease Treatment Revenue Share by Type (2021-2032) Figure 47. Europe Bromhidrosis Disease Treatment Sales Share by Type (2021-2032) Figure 48. Europe Bromhidrosis Disease Treatment Revenue Share by Application (2021-2032) Figure 49. Europe Bromhidrosis Disease Treatment Sales Share by Application (2021-2032) Figure 50. Europe Bromhidrosis Disease Treatment Revenue Share by Country (2021-2032) Figure 51. Europe Bromhidrosis Disease Treatment Sales Share by Country (2021-2032) Figure 52. China Bromhidrosis Disease Treatment Revenue Share by Type (2021-2032) Figure 53. China Bromhidrosis Disease Treatment Sales Share by Type (2021-2032) Figure 54. China Bromhidrosis Disease Treatment Revenue Share by Application (2021-2032) Figure 55. China Bromhidrosis Disease Treatment Sales Share by Application (2021-2032) Figure 56. Asia Bromhidrosis Disease Treatment Revenue Share by Type (2021-2032) Figure 57. Asia Bromhidrosis Disease Treatment Sales Share by Type (2021-2032) Figure 58. Asia Bromhidrosis Disease Treatment Revenue Share by Application (2021-2032) Figure 59. Asia Bromhidrosis Disease Treatment Sales Share by Application (2021-2032) Figure 60. Asia Bromhidrosis Disease Treatment Revenue Share by Country (2021-2032) Figure 61. Asia Bromhidrosis Disease Treatment Sales Share by Country (2021-2032) Figure 62. SAMEA Bromhidrosis Disease Treatment Revenue Share by Type (2021-2032) Figure 63. SAMEA Bromhidrosis Disease Treatment Sales Share by Type (2021-2032) Figure 64. SAMEA Bromhidrosis Disease Treatment Revenue Share by Application (2021-2032) Figure 65. SAMEA Bromhidrosis Disease Treatment Sales Share by Application (2021-2032) Figure 66. SAMEA Bromhidrosis Disease Treatment Revenue Share by Country (2021-2032) Figure 67. SAMEA Bromhidrosis Disease Treatment Sales Share by Country (2021-2032) Figure 68. Bromhidrosis Disease Treatment Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Bromhidrosis Disease Treatment Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Antiperspirants
  • Botulinum Toxin
  • Topical Antiseptic
Applications
  • Hospital
  • Drugs Store
  • Other
Companies covered
  • Johnson and Johnson
  • Novartis AG
  • Pfizer
  • AbbVie
  • Merz Pharma GmbH and Co. KGaA
  • Medytox
  • Journey Medical Corp
  • Ipsen Pharma
  • Hikma Pharmaceuticals
  • Galderma SA
  • Boehringer Ingelheim International GmbH
  • Biovencer Healthcare

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Bromhidrosis Disease Treatment Market by Type
  3. 1.2.1 Global Bromhidrosis Disease Treatment Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Antiperspirants
  5. 1.2.3 Botulinum Toxin
  6. 1.2.4 Topical Antiseptic
  7. 1.3 Bromhidrosis Disease Treatment Market by Application
  8. 1.3.1 Global Bromhidrosis Disease Treatment Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Hospital
  10. 1.3.3 Drugs Store
  11. 1.3.4 Other
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Bromhidrosis Disease Treatment Market Dynamics
  1. 2.1 Bromhidrosis Disease Treatment Industry Trends
  2. 2.2 Bromhidrosis Disease Treatment Industry Drivers
  3. 2.3 Bromhidrosis Disease Treatment Industry Opportunities and Challenges
  4. 2.4 Bromhidrosis Disease Treatment Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Bromhidrosis Disease Treatment Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Bromhidrosis Disease Treatment Revenue by Region
  3. 3.2.1 Global Bromhidrosis Disease Treatment Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Bromhidrosis Disease Treatment Revenue by Region (2021-2026)
  5. 3.2.3 Global Bromhidrosis Disease Treatment Revenue by Region (2027-2032)
  6. 3.2.4 Global Bromhidrosis Disease Treatment Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Bromhidrosis Disease Treatment Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Bromhidrosis Disease Treatment Sales by Region
  9. 3.4.1 Global Bromhidrosis Disease Treatment Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Bromhidrosis Disease Treatment Sales by Region (2021-2026)
  11. 3.4.3 Global Bromhidrosis Disease Treatment Sales by Region (2027-2032)
  12. 3.4.4 Global Bromhidrosis Disease Treatment Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Bromhidrosis Disease Treatment Revenue by Manufacturers
  2. 4.1.1 Global Bromhidrosis Disease Treatment Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Bromhidrosis Disease Treatment Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Bromhidrosis Disease Treatment Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Bromhidrosis Disease Treatment Sales by Manufacturers
  6. 4.2.1 Global Bromhidrosis Disease Treatment Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Bromhidrosis Disease Treatment Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Bromhidrosis Disease Treatment Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Bromhidrosis Disease Treatment Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Bromhidrosis Disease Treatment Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Bromhidrosis Disease Treatment Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Bromhidrosis Disease Treatment Manufacturers, Product Type & Application
  13. 4.7 Global Bromhidrosis Disease Treatment Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Bromhidrosis Disease Treatment Market CR5 and HHI
  16. 4.8.2 2025 Bromhidrosis Disease Treatment Tier 1, Tier 2, and Tier 3
5 Bromhidrosis Disease Treatment Market by Type
  1. 5.1 Global Bromhidrosis Disease Treatment Revenue by Type
  2. 5.1.1 Global Bromhidrosis Disease Treatment Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Bromhidrosis Disease Treatment Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Bromhidrosis Disease Treatment Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Bromhidrosis Disease Treatment Sales by Type
  6. 5.2.1 Global Bromhidrosis Disease Treatment Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Bromhidrosis Disease Treatment Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Bromhidrosis Disease Treatment Sales Market Share by Type (2021-2032)
  9. 5.3 Global Bromhidrosis Disease Treatment Price by Type
6 Bromhidrosis Disease Treatment Market by Application
  1. 6.1 Global Bromhidrosis Disease Treatment Revenue by Application
  2. 6.1.1 Global Bromhidrosis Disease Treatment Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Bromhidrosis Disease Treatment Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Bromhidrosis Disease Treatment Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Bromhidrosis Disease Treatment Sales by Application
  6. 6.2.1 Global Bromhidrosis Disease Treatment Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Bromhidrosis Disease Treatment Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Bromhidrosis Disease Treatment Sales Market Share by Application (2021-2032)
  9. 6.3 Global Bromhidrosis Disease Treatment Price by Application
7 Company Profiles
  1. 7.1 Johnson and Johnson
  2. 7.1.1 Johnson and Johnson Company Information
  3. 7.1.2 Johnson and Johnson Business Overview
  4. 7.1.3 Johnson and Johnson Bromhidrosis Disease Treatment Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Johnson and Johnson Bromhidrosis Disease Treatment Product Portfolio
  6. 7.1.5 Johnson and Johnson Recent Developments
  7. 7.2 Novartis AG
  8. 7.2.1 Novartis AG Company Information
  9. 7.2.2 Novartis AG Business Overview
  10. 7.2.3 Novartis AG Bromhidrosis Disease Treatment Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Novartis AG Bromhidrosis Disease Treatment Product Portfolio
  12. 7.2.5 Novartis AG Recent Developments
  13. 7.3 Pfizer
  14. 7.3.1 Pfizer Company Information
  15. 7.3.2 Pfizer Business Overview
  16. 7.3.3 Pfizer Bromhidrosis Disease Treatment Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Pfizer Bromhidrosis Disease Treatment Product Portfolio
  18. 7.3.5 Pfizer Recent Developments
  19. 7.4 AbbVie
  20. 7.4.1 AbbVie Company Information
  21. 7.4.2 AbbVie Business Overview
  22. 7.4.3 AbbVie Bromhidrosis Disease Treatment Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 AbbVie Bromhidrosis Disease Treatment Product Portfolio
  24. 7.4.5 AbbVie Recent Developments
  25. 7.5 Merz Pharma GmbH and Co. KGaA
  26. 7.5.1 Merz Pharma GmbH and Co. KGaA Company Information
  27. 7.5.2 Merz Pharma GmbH and Co. KGaA Business Overview
  28. 7.5.3 Merz Pharma GmbH and Co. KGaA Bromhidrosis Disease Treatment Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Merz Pharma GmbH and Co. KGaA Bromhidrosis Disease Treatment Product Portfolio
  30. 7.5.5 Merz Pharma GmbH and Co. KGaA Recent Developments
  31. 7.6 Medytox
  32. 7.6.1 Medytox Company Information
  33. 7.6.2 Medytox Business Overview
  34. 7.6.3 Medytox Bromhidrosis Disease Treatment Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Medytox Bromhidrosis Disease Treatment Product Portfolio
  36. 7.6.5 Medytox Recent Developments
  37. 7.7 Journey Medical Corp
  38. 7.7.1 Journey Medical Corp Company Information
  39. 7.7.2 Journey Medical Corp Business Overview
  40. 7.7.3 Journey Medical Corp Bromhidrosis Disease Treatment Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Journey Medical Corp Bromhidrosis Disease Treatment Product Portfolio
  42. 7.7.5 Journey Medical Corp Recent Developments
  43. 7.8 Ipsen Pharma
  44. 7.8.1 Ipsen Pharma Company Information
  45. 7.8.2 Ipsen Pharma Business Overview
  46. 7.8.3 Ipsen Pharma Bromhidrosis Disease Treatment Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Ipsen Pharma Bromhidrosis Disease Treatment Product Portfolio
  48. 7.8.5 Ipsen Pharma Recent Developments
  49. 7.9 Hikma Pharmaceuticals
  50. 7.9.1 Hikma Pharmaceuticals Company Information
  51. 7.9.2 Hikma Pharmaceuticals Business Overview
  52. 7.9.3 Hikma Pharmaceuticals Bromhidrosis Disease Treatment Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Hikma Pharmaceuticals Bromhidrosis Disease Treatment Product Portfolio
  54. 7.9.5 Hikma Pharmaceuticals Recent Developments
  55. 7.10 Galderma SA
  56. 7.10.1 Galderma SA Company Information
  57. 7.10.2 Galderma SA Business Overview
  58. 7.10.3 Galderma SA Bromhidrosis Disease Treatment Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Galderma SA Bromhidrosis Disease Treatment Product Portfolio
  60. 7.10.5 Galderma SA Recent Developments
  61. 7.11 Boehringer Ingelheim International GmbH
  62. 7.11.1 Boehringer Ingelheim International GmbH Company Information
  63. 7.11.2 Boehringer Ingelheim International GmbH Business Overview
  64. 7.11.3 Boehringer Ingelheim International GmbH Bromhidrosis Disease Treatment Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Boehringer Ingelheim International GmbH Bromhidrosis Disease Treatment Product Portfolio
  66. 7.11.5 Boehringer Ingelheim International GmbH Recent Developments
  67. 7.12 Biovencer Healthcare
  68. 7.12.1 Biovencer Healthcare Company Information
  69. 7.12.2 Biovencer Healthcare Business Overview
  70. 7.12.3 Biovencer Healthcare Bromhidrosis Disease Treatment Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Biovencer Healthcare Bromhidrosis Disease Treatment Product Portfolio
  72. 7.12.5 Biovencer Healthcare Recent Developments
8 North America
  1. 8.1 North America Bromhidrosis Disease Treatment Market Size by Type
  2. 8.1.1 North America Bromhidrosis Disease Treatment Revenue by Type (2021-2032)
  3. 8.1.2 North America Bromhidrosis Disease Treatment Sales by Type (2021-2032)
  4. 8.1.3 North America Bromhidrosis Disease Treatment Price by Type (2021-2032)
  5. 8.2 North America Bromhidrosis Disease Treatment Market Size by Application
  6. 8.2.1 North America Bromhidrosis Disease Treatment Revenue by Application (2021-2032)
  7. 8.2.2 North America Bromhidrosis Disease Treatment Sales by Application (2021-2032)
  8. 8.2.3 North America Bromhidrosis Disease Treatment Price by Application (2021-2032)
  9. 8.3 North America Bromhidrosis Disease Treatment Market Size by Country
  10. 8.3.1 North America Bromhidrosis Disease Treatment Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Bromhidrosis Disease Treatment Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Bromhidrosis Disease Treatment Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Bromhidrosis Disease Treatment Market Size by Type
  2. 9.1.1 Europe Bromhidrosis Disease Treatment Revenue by Type (2021-2032)
  3. 9.1.2 Europe Bromhidrosis Disease Treatment Sales by Type (2021-2032)
  4. 9.1.3 Europe Bromhidrosis Disease Treatment Price by Type (2021-2032)
  5. 9.2 Europe Bromhidrosis Disease Treatment Market Size by Application
  6. 9.2.1 Europe Bromhidrosis Disease Treatment Revenue by Application (2021-2032)
  7. 9.2.2 Europe Bromhidrosis Disease Treatment Sales by Application (2021-2032)
  8. 9.2.3 Europe Bromhidrosis Disease Treatment Price by Application (2021-2032)
  9. 9.3 Europe Bromhidrosis Disease Treatment Market Size by Country
  10. 9.3.1 Europe Bromhidrosis Disease Treatment Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Bromhidrosis Disease Treatment Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Bromhidrosis Disease Treatment Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Bromhidrosis Disease Treatment Market Size by Type
  2. 10.1.1 China Bromhidrosis Disease Treatment Revenue by Type (2021-2032)
  3. 10.1.2 China Bromhidrosis Disease Treatment Sales by Type (2021-2032)
  4. 10.1.3 China Bromhidrosis Disease Treatment Price by Type (2021-2032)
  5. 10.2 China Bromhidrosis Disease Treatment Market Size by Application
  6. 10.2.1 China Bromhidrosis Disease Treatment Revenue by Application (2021-2032)
  7. 10.2.2 China Bromhidrosis Disease Treatment Sales by Application (2021-2032)
  8. 10.2.3 China Bromhidrosis Disease Treatment Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Bromhidrosis Disease Treatment Market Size by Type
  2. 11.1.1 Asia Bromhidrosis Disease Treatment Revenue by Type (2021-2032)
  3. 11.1.2 Asia Bromhidrosis Disease Treatment Sales by Type (2021-2032)
  4. 11.1.3 Asia Bromhidrosis Disease Treatment Price by Type (2021-2032)
  5. 11.2 Asia Bromhidrosis Disease Treatment Market Size by Application
  6. 11.2.1 Asia Bromhidrosis Disease Treatment Revenue by Application (2021-2032)
  7. 11.2.2 Asia Bromhidrosis Disease Treatment Sales by Application (2021-2032)
  8. 11.2.3 Asia Bromhidrosis Disease Treatment Price by Application (2021-2032)
  9. 11.3 Asia Bromhidrosis Disease Treatment Market Size by Country
  10. 11.3.1 Asia Bromhidrosis Disease Treatment Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Bromhidrosis Disease Treatment Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Bromhidrosis Disease Treatment Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Bromhidrosis Disease Treatment Market Size by Type
  2. 12.1.1 SAMEA Bromhidrosis Disease Treatment Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Bromhidrosis Disease Treatment Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Bromhidrosis Disease Treatment Price by Type (2021-2032)
  5. 12.2 SAMEA Bromhidrosis Disease Treatment Market Size by Application
  6. 12.2.1 SAMEA Bromhidrosis Disease Treatment Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Bromhidrosis Disease Treatment Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Bromhidrosis Disease Treatment Price by Application (2021-2032)
  9. 12.3 SAMEA Bromhidrosis Disease Treatment Market Size by Country
  10. 12.3.1 SAMEA Bromhidrosis Disease Treatment Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Bromhidrosis Disease Treatment Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Bromhidrosis Disease Treatment Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Bromhidrosis Disease Treatment Value Chain Analysis
  2. 13.1.1 Bromhidrosis Disease Treatment Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Bromhidrosis Disease Treatment Production Mode & Process
  6. 13.2 Bromhidrosis Disease Treatment Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Bromhidrosis Disease Treatment Distributors
  9. 13.2.3 Bromhidrosis Disease Treatment Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst